Oral mucosal surface at the ulcer margin

The oral mucosal surface at the ulcer margin represents the perilesional tissue zone critical for the pathophysiology and resolution of oral ulcerative conditions such as recurrent aphthous stomatitis and chemotherapy-induced mucositis (StatPearls, 2023). This region is the focal point for re-epithelialization, where keratinocytes migrate from the periphery to close the wound, and it serves as a hub for inflammatory cell infiltration and cytokine signaling (Journal of Oral Pathology & Medicine, 2019). While not a discrete molecular target, the margin is the primary site for the application of topical therapeutics, including anti-inflammatory agents like Amlexanox and physical barriers like hyaluronic acid gels (Mayo Clinic, 2023). These treatments aim to modulate the local microenvironment to reduce pain and accelerate healing. Consequently, the ulcer margin is a clinical endpoint site rather than a specific receptor or enzyme, making it a target only in the sense of drug delivery and anatomical focus.

Other names

Ulcer peripheryPerilesional oral mucosaMargin of oral ulcer

Topical agents applied to the ulcer margin function by suppressing local inflammatory mediators, providing a physical protective barrier over exposed nerve endings, or exerting antimicrobial effects to prevent secondary infection.